Related Experiment Video
Updated: May 17, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
Published on: December 4, 2020
[Microbiologic basis of diagnosis and treatment of pelvic inflammatory disease]
1Service de bactériologie et hygiène hospitalière, CHRU de Tours, 37044 Tours, France. roland.quentin@dbmail.com
Abstract:
Pelvic inflammatory disease (PID) is caused by a large spectrum of micro-organisms. However, the microbiological cause is unknown in approximately half of cases according to varying series. In the context of sexually transmitted disease (STD), the most frequently identified microorganisms causing PID are Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium. In such cases, bacterial vaginosis and Trichomonas vaginalis are frequently associated. In case of complicated PID or when PID is the consequence of delivery, abortion, intra-uterine procedure, bacteria that come from vaginal carriage may be encountered: Enterobacteriacae, Staphylococcus spp., Streptococcus spp., anaerobes. Mycopslama hominis as well as Ureaplasma urealyticum may also be found in this context. The microbiological diagnosis may be performed on samples of vaginal liquid, endocervix or, when available, surgical specimens. The microbiological diagnostic procedures that are used to identify these microrgansims are reviewed. Vaginal sampling may help to identify N. gonorrhoeae, C. trachomatis and M. genitalium using nucleic acid amplification tests (NAAT), and is also of interest because of the epidemiological association of PID to bacterial vaginosis and trichomoniasis. Samples from the endocervix, and if available, from endometrial biopsy surgical procedures, should be processed to detect N. gonorrhoeae, C. trachomatis and M. genitalium using NAAT, and to search for the presence of Neisseria gonorrhoeae (antibiogram should be performed), facultative anaerobes, anaerobes and capnophilic bacteria. The antibiotic treatment should at least cover N. gonorrhoeae, C. trachomatis and M. genitalium, and for most of the authors, anaerobes. In case, microbiological studies demonstrate the role of other bacteria (e.g., Enterobacteriacae), theses should be treated according to the results of antibiogram.
Insights
Pelvic inflammatory disease (PID) is often caused by sexually transmitted infections like gonorrhea and chlamydia, but other bacteria can be involved. Accurate microbiological diagnosis is key for effective antibiotic treatment of PID.
Area of Science:
- Microbiology
- Infectious Diseases
- Gynecology
Background:
- Pelvic inflammatory disease (PID) has diverse etiological agents, with the specific cause remaining unidentified in a significant proportion of cases.
- Sexually transmitted infections (STIs), particularly Neisseria gonorrhoeae and Chlamydia trachomatis, are primary drivers of PID.
- Bacterial vaginosis and Trichomonas vaginalis are frequently associated with PID, complicating diagnosis and treatment.
Purpose of the Study:
- To review the spectrum of microorganisms implicated in pelvic inflammatory disease (PID).
- To outline current microbiological diagnostic procedures for identifying PID pathogens.
- To correlate microbiological findings with appropriate antibiotic treatment strategies for PID.
Main Methods:
- Analysis of microbiological causes of PID, including common STIs and other bacterial pathogens.
- Review of diagnostic techniques utilizing vaginal fluid, endocervical, and surgical specimens.
- Application of nucleic acid amplification tests (NAATs) for detecting key pathogens like N. gonorrhoeae and C. trachomatis.
Main Results:
- Neisseria gonorrhoeae, Chlamydia trachomatis, and Mycoplasma genitalium are the most frequent microbial causes of PID in the context of STDs.
- Bacterial vaginosis and Trichomonas vaginalis are common co-infections.
- In complicated PID or post-procedural cases, vaginal carriage bacteria (Enterobacteriaceae, Staphylococcus, Streptococcus, anaerobes) and Mycoplasma hominis/Ureaplasma urealyticum may be involved.
- Microbiological diagnosis involves NAATs on various sample types and culture for specific bacteria, including antibiotic susceptibility testing.
Conclusions:
- Effective PID management requires broad-spectrum antibiotic treatment covering common STIs and anaerobes.
- Tailoring antibiotic therapy based on microbiological results, including antibiograms, is crucial for complicated cases or when non-STI pathogens are identified.
- Accurate and timely microbiological diagnosis is essential for optimizing PID treatment outcomes.
Related Concept Videos
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection II: Pathophysiology
Microbiota of the Urogenital Tract
Acute Pyelonephritis II: Diagnostic Studies and Management
Sexually Transmitted Infections
Urinary Tract Infection I: Introduction

